ENJAYMO (sutimlimab-jome) injection

ENJAYMO is a classical complement inhibitor indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease (CAD)

BLA 761164
Drug Name: ENJAYMO
Active Ingredient: SUTIMLIMAB-JOME
Company: BIOVERATIV USA INC
Approval Date: 25-Jan-2023
FDA-approved use on approval date: Treatment of hemolysis in adults with cold agglutinin disease (CAD)
Dosage Forms And Strengths: Injection: 1,100 mg/22 mL (50 mg/mL) in a single-dose vial

Request ENJAYMO (sutimlimab-jome) Communication – Important Information
If ENJAYMO (sutimlimab-jome) is not available in your country, and you require assistance to get access this medication under “Named Patient Program (NPP)” treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon, please send us a formal request for communication regarding this medication at urgent@cancermedicinesnetwork.com or call a customer support or WhatsApp your query

Please Note:
ENJAYMO (sutimlimab-jome) is a prescription medication. A valid prescription from a licensed healthcare provider is required for any request.

Get In Touch

Get in touch with us at Verve Biscience, and one of our team will be on hand to help with any queries you may have.

The Verve Biscience is open
Monday to Saturday.
Business hours: 10.00 A.M to 06.00 P.M.

Contact Number:
M:+91-9910645395

Email ID:
info@cancermedicinesnetwork.com
rakeshkhanna.rk@gmail.com

Description

Sutimlimab is indicated to decrease the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold agglutinin disease (CAD).

The most common side effects include respiratory tract infection, viral infection, diarrhea, dyspepsia (indigestion), cough, arthralgia (joint stiffness), arthritis, and swelling in the lower legs and hands.[3] In two phase 3 studies (n=66), 29% of patients experienced infusion-related reactions, including shortness of breath, rapid heartbeat, nausea, flushing, headache, hypotension, chest discomfort, pruritis, rash, injection site reaction, and dizziness.

ENJAYMO (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 2022

See full prescribing information : Click Here

How to get access ENJAYMO (sutimlimab-jome) for personal use ?

To get access to ENJAYMO (sutimlimab-jome), you need a prescription from a doctor, as it is a prescription-only medication. Your prescription will be filled through a specialty pharmacy, which will handle insurance and coordinate delivery of the medication to you. Your doctor will also need to provide specific information for the prescription to be filled correctly.

However, patients in India can legally access it through the provision called the Named Patient Program (NPP). ENJAYMO (sutimlimab-jome) prices may fluctuate over time because of market dynamics and regulatory changes. It can be imported for personal use under “Named Patient Program” treatment in multiple countries, including the Singapore, Kuala Lumpur (Malaysia), Bangkok (Thailand), Jakarta, Surabaya, Bandung (Indonesia), Manila, Cebu (Philippines), Ho Chi Minh City, Hanoi (Vietnam), Yangon (Myanmar), Phnom Penh (Cambodia), Vientiane (Laos), UAE, Saudi Arabia, Argentina, Brazil, UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithuania, Greece, Spain, Zimbabwe, Australia, and New Zealand.

To order or inquire about ENJAYMO (sutimlimab-jome) international access, you can contact Verve Biosciences – a trusted pharmaceutical exporter, supplier, and distributor of anti-cancer and specialty medications.

📧 Email: urgent@cancermedicinesnetwork.com
📞 Call or WhatsApp: 9910645395 or 9910645395

Note: Availability may vary by country and is subject to regulatory approvals.

Delivered Countries

Serving over 65 countries worldwide with reliable pharmaceutical shipping across Asia-Pacific, Africa, Europe, the Middle East, North and South America.

North & South America: Canada, US, Mexico, Guatemala, El Salvador, Honduras, Costa Rica, Nicaragua, Panama, Cuba, Dominican Republic, Venezuela, Brazil, Bolivia, Chile, Peru, Ecuador Argentina, Columbia etc.
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
Middle East (Saudi Arabia, UAE, Egypt)
Africa: Ghana, Burkina, Togo, Benin, Nigeria, Nigeria, Cameroon, Sudan, Eritrea, Ethiopia, Somalia, Republic of Congo, (Democratic Republic of) Congo, Uganda, Kenya, Rwanda, Burundi, Tanzania, Zambia, Mozambique, Namibia, Botswana, Zimbabwe, South Africa.

FAQs

Is sutimlimab available in India?

No, sutimlimab (marketed as ENJAYMO) is not yet available in India.

Can we Import sutimlimab (ENJAYMO) in India?

Import sutimlimab (ENJAYMO) in India Under Named Patient Program – Available in Major Cities

sutimlimab (marketed as ENJAYMO), an FDA-approved treatment for hemolysis, can be imported into India under the Named Patient Program (NPP). This program allows patients access to medications that are not yet commercially available in the country.

sutimlimab can be made available in major Indian cities, including:
Mumbai, Delhi, Gurgaon, Noida, Chandigarh, Jaipur, Srinagar, Jammu, Kolkata, Chennai, Bengaluru, Hyderabad, Ahmedabad, Pune, and Surat.

To learn about the cost price of ENJAYMO (sutimlimab) or to order sutimlimab online, please contact:
📞 Mr. Rakesh: +91 9910645395
📧 Email: info@cancermedicinesnetwork.com

We ensure genuine quality, secure delivery, and compliance with all buyer requirements.

About Healthcare Consultant

Rakesh brings an experience of 37 years in the pharmaceutical industry at various roles and responsibilities in Indian and US pharma MNCs. His areas of operations have been India and Southeast Asia, and he has been running a successful pharma business since 2010.

Testimonials

Frequently Asked Questions (FAQs)

No. At present. This medicine is not approved by the Drug Controller General Of India (DCGI).

It is a prescription medicine. You should have a VALID and RECENT Prescription.

No, we do not sell rather we just FACILITATE the Procurement of this Medicine in India

Yes, We do. Since we facilitate the Procurement of Medicines directly from the International companies and that too with all Legal Documents like International Comp. Invoice, Air Way Bill (AWB) and Bill Of Entry (BOE), we Guarantee for it.

It would take you 12-17 Working Days as it requires Govt Approvals/Certificates and coordination with an International company.

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

We are 24 Hours * 7 Days Available through our Website and Mobile Numbers?

Related Products